998 resultados para 1995_12130058 CTD-73 5401502
Resumo:
recombinant activated factor VII (rFVIIa) is used off-label for massive bleeding. There is no convincing evidence of the benefits of this practice and the minimal effective dose is unknown. The aim of the study was to evaluate our in-house guideline recommending a low dose of 60 μg/kg for off-label use of rFVIIa.
Resumo:
von J. Norden. Hrsg. vom "Verein f. jüd. Geschichte u. Litteratur"
Resumo:
Vorbesitzer: Abraham Merzbacher
Resumo:
Vorbesitzer: Theodericus Franck; Hermann Isenbach; Bartholomaeusstift Frankfurt am Main
Resumo:
Martin Buber